Yahoo Web Search

  1. Yahoo Finance Results

  2. Better Buy: Pfizer Inc. vs. Eli Lilly and Company

    Motley Fool via Yahoo FinanceSep 04 13:31 PM

    With new products heading toward blockbuster status and some nearly ready for an FDA review, shares of Pfizer Inc. (NYSE: PFE) and Eli Lilly and Company (NYSE: LLY) have risen ...

  3. This could indicate that investors who seek to profit from falling equity prices are not currently targeting PFE. Index (PMI) data, output in the Healthcare sector is rising.

    44.06+0.31 (+0.71%)

    at Fri, Sep 21, 2018, 15:00PM EST - U.S. Markets open in 1 hr 16 mins

    Pre Mkt 44.06 N/A (N/A%)

    Nasdaq Real Time Price

    • Ask Price 43.95
    • Bid Price 43.75
    • P/E 11.77
    • 52 Wk. High 44.20
    • 52 Wk. Low 33.20
    • Mkt. Cap 258.28B
  4. Pfizer Estimates Brexit Costs at $100 Million as Talks Drag

    Bloomberg via Yahoo FinanceSep 04 4:00 AM

    Pfizer Inc., the U.S.-based drug behemoth, says its costs for dealing with the upcoming split will reach $100 million. The U.K.’s looming rupture with the European Union threatens ...

  5. 3 Small Biotech Stocks That Almost Doubled in Past Month

    Zacks via Yahoo FinanceSep 11 14:24 PM

    Meanwhile, with big pharma and biotech companies like Merck & Co, Inc. MRK, Pfizer, Inc. PFE, Amgen, Inc. AMGN and others in trouble due to generic competition among ...

  6. How Companies Are Preparing for Hurricane Florence

    Fortune via Yahoo FinanceSep 11 17:45 PM

    Pfizer Inc. is suspending operations Thursday at two facilities in North Carolina, including a Rocky Mount plant that supplies hospitals with drugs from its sterile injectibles ...

  7. Pfizer said in an email that its costs stem from transferring product testing and licenses to other countries, changing clinical trial management procedures, and other preventive measures ...

  8. Stocks recently featured in the blog include Pfizer PFE, Salesforce CRM, ADP ADP, General Motors GM and Southwest Airlines LUV. Today, Zacks is promoting its ''Buy'' stock recommendations ...

  9. Exelixis, Inc. EXEL announced that the National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines to include new recommendations for lead drug Cabometyx ...

  10. In that same time, the Medical sector gained 4.33%, while the S&P 500 gained 3.1%. For the full year, our Zacks Consensus Estimates are projecting earnings of $2.99 per share and revenue of ...

  11. Novartis to Sell Parts of Sandoz for $1 Billion: Novartis said it will sell selected portions of the Sandoz US portfolio, comprising approximately 300 products, to Aurobindo Pharma USA Inc ...

  1. Ads
    related to PFIZER, INC